92
Views
57
CrossRef citations to date
0
Altmetric
Research Article

Selenium supplementation in rheumatoid arthritis investigated in a double blind, placebo-controlled trial

Pages 208-212 | Published online: 12 Jul 2009
 

Abstract

Introduction: Selenium is an essential trace element with antioxidant properties. Trials with selenium have been conducted in rheumatoid arthritis (RA) to correct impaired selenium status and increase defences against deleterious oxidant species. Aim of the study: To investigate in a double blind multi-centric placebo-controlled study the effects of selenium supplementation in RA. Methods: Fifty five patients with moderate RA received during 90 days either capsules containing selenium-enriched yeast (200 μg/d) or a placebo. Results: The visual analog scale, the Ritchie index, the number of swollen and painful joints, and morning stiffness significantly decreased with time in both groups (p< 0.001), but no difference between groups could be identified. When examining the quality of life a significant (p< 0.01) improvement in arm movements and health feeling was evidenced in selenium-treated patients. Conclusion: Selenium treatment did not show clinical benefit on RA. Interestingly, the improval in both groups demonstrated a placebo effect of the intervention trial.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.